Clinical Trial Update: Evaluation of Psilocybin-Assisted Psychotherapy in Treating Severe Depression in Patients With PTSD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating psilocybin-assisted psychotherapy for severe depression in patients with PTSD is in progress with status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• psilocybin-assisted psychotherapy (psilocybin)

Snippet

Sponsor: Apex Labs Ltd. | Conditions: Post-traumatic Stress Disorder, Depression | Phase 2 | Status: UNKNOWN